Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference
NEW YORK--(BUSINESS WIRE)--Nov 7, 2018--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Credit Suisse Annual Health Care Conference on Wednesday, November 14, 2018 in Scottsdale, AZ. Chris Boerner, chief commercial officer, will answer questions about the company at 8 a.m. MT (10 a.m. ET).
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181107005011/en/
CONTACT: Bristol-Myers Squibb Company
Lisa McCormick Lavery,609-252-7602
Tim Power, 609-252-7509
Bill Szablewski, 609-252-5894
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL
SOURCE: Bristol-Myers Squibb Company
Copyright Business Wire 2018.
PUB: 11/07/2018 06:59 AM/DISC: 11/07/2018 06:59 AM